The results of western blotting implied that BCL-2, CDK2, PI3K and AKT were downregulated, and the protein expression of BAX and Caspase 3 was upregulated, suggesting that SDF may regulate the PI3K/AKT signaling pathway for the treatment of BC. This evidence concerns the gene AKT1 and breast cancer.